On Friday, Vir Biotechnology Inc (NASDAQ: VIR) was 5.98% up from the session before settling in for the closing price of $5.18. A 52-week range for VIR has been $4.16 – $14.45.
A company in the Healthcare sector has dropped its sales by -18.74% annually for the last half of the decade. When this article was written, the company’s average yearly earnings per share was at 15.15%. With a float of $90.45 million, this company’s outstanding shares have now reached $138.89 million.
Vir Biotechnology Inc (VIR) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Vir Biotechnology Inc stocks. The insider ownership of Vir Biotechnology Inc is 34.89%, while institutional ownership is 56.98%. The most recent insider transaction that took place on Sep 02 ’25, was worth 109,811. In this transaction Director of this company sold 22,000 shares at a rate of $4.99, taking the stock ownership to the 1,254,391 shares. Before that another transaction happened on Aug 01 ’25, when Company’s Director sold 22,000 for $4.99, making the entire transaction worth $109,699. This insider now owns 1,276,391 shares in total.
Vir Biotechnology Inc (VIR) Latest Financial update
Going through the last 3-months fiscal report unveiled on the 9/30/2024, it has been observed that the corporation posted -1.56 earnings per share (EPS) during the time that was less than consensus figure (set at -1.08) by -0.48. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.71 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 15.15% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 15.25% during the next five years compared to -18.74% drop over the previous five years of trading.
Vir Biotechnology Inc (NASDAQ: VIR) Trading Performance Indicators
You can see what Vir Biotechnology Inc (VIR) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 7.01. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 40.14.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.01, a number that is poised to hit -0.84 in the next quarter and is forecasted to reach -2.81 in one year’s time.
Technical Analysis of Vir Biotechnology Inc (VIR)
Let’s dig in a bit further. During the last 5-days, its volume was 1.18 million. That was inferior than the volume of 1.56 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 75.38%.
During the past 100 days, Vir Biotechnology Inc’s (VIR) raw stochastic average was set at 64.34%, which indicates a significant decrease from 97.37% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.25 in the past 14 days, which was lower than the 0.28 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.00, while its 200-day Moving Average is $6.51. However, in the short run, Vir Biotechnology Inc’s stock first resistance to watch stands at $5.62. Second resistance stands at $5.74. The third major resistance level sits at $5.98. If the price goes on to break the first support level at $5.26, it is likely to go to the next support level at $5.02. The third support level lies at $4.90 if the price breaches the second support level.
Vir Biotechnology Inc (NASDAQ: VIR) Key Stats
There are 138,916K outstanding shares of the company, which has a market capitalization of 762.65 million. As of now, sales total 74,210 K while income totals -521,960 K. Its latest quarter income was 1,210 K while its last quarter net income were -110,960 K.
